American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
+$769M |
| 2 |
Kenvue
KVUE
|
+$204M |
| 3 |
Entegris
ENTG
|
+$176M |
| 4 |
Merck
MRK
|
+$148M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
+$143M |
Top Sells
| 1 |
Nike
NKE
|
+$278M |
| 2 |
Visa
V
|
+$272M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$228M |
| 4 |
Allstate
ALL
|
+$188M |
| 5 |
Wingstop
WING
|
+$165M |
Sector Composition
| 1 | Technology | 25.16% |
| 2 | Financials | 13.26% |
| 3 | Healthcare | 12.3% |
| 4 | Consumer Discretionary | 12.01% |
| 5 | Industrials | 10.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2526
Citizens Financial Services
CZFS
$311M
| $365K | ﹤0.01% |
7,565
+503
| +7% | +$24.3K |
|
2527
Hippo Holdings
HIPO
$933M
| $363K | ﹤0.01% |
19,861
+5,182
| +35% | +$94.7K |
|
|
NVRO
2528
DELISTED
NEVRO CORP.
NVRO
| $363K | ﹤0.01% |
25,104
+7,920
| +46% | +$114K |
|
2529
Empire State Realty Trust
ESRT
$1.34B
| $361K | ﹤0.01% |
35,633
+16,612
| +87% | +$168K |
|
|
CBD
2530
DELISTED
Companhia Brasileira de Distribuicao
CBD
| $361K | ﹤0.01% |
572,936
+781
| +0.1% | +$492 |
|
2531
Invivyd
IVVD
$299M
| $360K | ﹤0.01% |
+81,113
| New | +$360K |
|
2532
Enanta Pharmaceuticals
ENTA
$177M
| $360K | ﹤0.01% |
20,605
+9,975
| +94% | +$174K |
|
2533
Blackbaud
BLKB
$3.38B
| $359K | ﹤0.01% |
4,848
-258,643
| -98% | -$19.2M |
|
2534
Fresenius Medical Care
FMS
$14.7B
| $359K | ﹤0.01% |
18,601
| – | – |
|
2535
Group 1 Automotive
GPI
$6.03B
| $358K | ﹤0.01% |
1,225
-3,314
| -73% | -$968K |
|
2536
Terns Pharmaceuticals
TERN
$633M
| $357K | ﹤0.01% |
54,484
+26,050
| +92% | +$171K |
|
2537
LifeVantage
LFVN
$141M
| $355K | ﹤0.01% |
58,728
| – | – |
|
|
AGR
2538
DELISTED
Avangrid, Inc.
AGR
| $355K | ﹤0.01% |
9,743
+657
| +7% | +$23.9K |
|
|
ALEX
2539
Alexander & Baldwin
ALEX
$1.34B
| $354K | ﹤0.01% |
21,516
+2,138
| +11% | +$35.2K |
|
2540
Grid Dynamics Holdings
GDYN
$642M
| $354K | ﹤0.01% |
28,798
-121
| -0.4% | -$1.49K |
|
2541
Replimune Group
REPL
$447M
| $353K | ﹤0.01% |
43,198
+10,332
| +31% | +$84.4K |
|
2542
Dayforce
DAY
$10.9B
| $353K | ﹤0.01% |
5,324
| – | – |
|
2543
Boston Omaha
BOC
$425M
| $351K | ﹤0.01% |
22,728
+4,931
| +28% | +$76.2K |
|
2544
Zynex
ZYXI
$44.8M
| $350K | ﹤0.01% |
28,295
+6,992
| +33% | +$86.5K |
|
2545
Cogent Biosciences
COGT
$1.77B
| $350K | ﹤0.01% |
52,029
+1,052
| +2% | +$7.07K |
|
2546
Copel
ELPC
$6.38B
| $349K | ﹤0.01% |
51,839
| – | – |
|
2547
Larimar Therapeutics
LRMR
$336M
| $346K | ﹤0.01% |
45,636
+34,120
| +296% | +$259K |
|
2548
Crawford & Co Class B
CRD.B
$494M
| $345K | ﹤0.01% |
38,033
+22,502
| +145% | +$204K |
|
2549
Neurogene
NGNE
$271M
| $343K | ﹤0.01% |
+6,747
| New | +$343K |
|
2550
Leonardo DRS
DRS
$11.2B
| $343K | ﹤0.01% |
15,535
+554
| +4% | +$12.2K |
|